Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Clinical Trials as Topic
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Practice Guidelines as Topic

abstract

  • Clinical trials with anti-EGF receptor MAbs are being conducted, and trials with anti-EGF receptor MAbs combined with doxorubicin are planned.

publication date

  • August 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1093/jnci/85.16.1327

PubMed ID

  • 8340945

Additional Document Info

start page

  • 1327

end page

  • 33

volume

  • 85

number

  • 16